Literature DB >> 24613539

Increased expression of antimüllerian hormone and its receptor in endometriosis.

Patrizia Carrarelli1, Ana Luiza Lunardi Rocha2, Giuseppe Belmonte3, Errico Zupi1, Mauricio Simoẽs Abrão4, Felice Arcuri1, Paola Piomboni1, Felice Petraglia5.   

Abstract

OBJECTIVE: To evaluate antimüllerian hormone (AMH) and AMH receptor II (AMHRII) mRNA and protein expression in endometrium and in ovarian or deep lesions of women with endometriosis.
DESIGN: Prospective study.
SETTING: University hospitals in Italy and Brazil. PATIENTS: Patients with endometriosis (n = 55) and healthy women (n = 45).
INTERVENTIONS: Specimens of endometrium obtained by hysteroscopy from patients with endometriosis and from healthy control subjects; specimens of ovarian endometriosis (n = 29) or of deep endometriosis (n = 26) were collected by laparoscopy. Serum samples were collected in some endometriotic patients (n = 23) and healthy control subjects (n = 20). MAIN OUTCOME MEASURE(S): AMH and AMHRII mRNA levels were evaluated by quantitative reverse-transcription polymerase chain reaction and protein localization by immunohistochemistry. AMH levels in tissue homogenates and in serum were assessed by ELISA. RESULT(S): Endometrium from women with endometriosis showed higher AMH and AMHRII mRNA levels than control women, with no significant differences between proliferative and secretory phases. Specimens collected from ovarian or deep endometriosis showed the highest AMH and AMHRII mRNA expression. Immunolocalization study confirmed the high AMH and AMHRII protein expression in endometriotic lesions. No difference of serum AMH levels between the groups was found. CONCLUSION(S): The increased AMH and AMHRII mRNA and protein expression in endometrium and in endometriotic lesions suggests a possible involvement of AMH in endometriosis.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMH; AMHRII; TGF-β superfamily; endometriosis; ovarian and deep endometriosis

Mesh:

Substances:

Year:  2014        PMID: 24613539     DOI: 10.1016/j.fertnstert.2014.01.052

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

Review 1.  Pathophysiology and management of urinary tract endometriosis.

Authors:  Camran Nezhat; Rebecca Falik; Sara McKinney; Louise P King
Journal:  Nat Rev Urol       Date:  2017-05-03       Impact factor: 14.432

Review 2.  Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.

Authors:  Vitaly A Kushnir; David B Seifer; David H Barad; Aritro Sen; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2017-06-22       Impact factor: 3.412

Review 3.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Authors:  Jure Bedenk; Eda Vrtačnik-Bokal; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

4.  Diagnostic and treatment guidelines for gastrointestinal and genitourinary endometriosis.

Authors:  Stacy Young; Megan Kennedy Burns; Lucia DiFrancesco; Azadeh Nezhat; Camran Nezhat
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-12-15

5.  Anti-Mullerian hormone concentrations in individual follicular fluids within one stimulated IVF cycle resemble blood serum values.

Authors:  Michael Schenk; Julia Maria Kröpfl; Barbara Obermayer-Pietsch; Elisabeth Feldmeier; Gregor Weiss
Journal:  J Assist Reprod Genet       Date:  2017-03-21       Impact factor: 3.412

6.  Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.

Authors:  Renée T Fortner; Helena Schock; Seungyoun Jung; Naomi E Allen; Alan A Arslan; Louise A Brinton; Brian L Egleston; Roni T Falk; Marc J Gunter; Kathy J Helzlsouer; Annika Idahl; Theron S Johnson; Rudolf Kaaks; Vittorio Krogh; Eva Lundin; Melissa A Merritt; Carmen Navarro; N Charlotte Onland-Moret; Domenico Palli; Xiao-Ou Shu; Patrick M Sluss; Paul N Staats; Antonia Trichopoulou; Elisabete Weiderpass; Anne Zeleniuch-Jacquotte; Wei Zheng; Joanne F Dorgan
Journal:  Br J Cancer       Date:  2017-09-05       Impact factor: 7.640

7.  AMH Concentrations in Peritoneal Fluids of Women With and Without Endometriosis.

Authors:  Michio Kitajima; Kanako Matsumoto; Naoko Murakami; Itsuki Kajimura; Ayumi Harada; Yuriko Kitajima; Hideaki Masuzaki; Kiyonori Miura
Journal:  Front Surg       Date:  2020-11-11

Review 8.  Maximizing the clinical utility of antimüllerian hormone testing in women's health.

Authors:  Benjamin Leader; Valerie L Baker
Journal:  Curr Opin Obstet Gynecol       Date:  2014-08       Impact factor: 1.927

9.  Seminal Plasma Anti-Müllerian Hormone: A Potential AI-Boar Fertility Biomarker?

Authors:  Isabel Barranco; Beatriz Fernandez-Fuertes; Lorena Padilla; Ariadna Delgado-Bermúdez; Asta Tvarijonaviciute; Marc Yeste
Journal:  Biology (Basel)       Date:  2020-04-10

10.  High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology.

Authors:  Reshef Tal; Charles M Seifer; Moisey Khanimov; David B Seifer; Oded Tal
Journal:  Reprod Biol Endocrinol       Date:  2020-03-10       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.